International Research Congress on FSHD 2025

Back

DYNE-302 leads to functional improvement and resolves muscle transcriptomic changes in mouse models of FSHD (presentation)

View

©2026 Dyne Therapeutics, Inc. All rights reserved MED-00978. Date of preparation: July 2026.